PI3Kα/δ inhibition promotes anti-tumor immunity through direct enhancement of effector CD8+ T-cell activity

Overview of attention for article published in Journal for Immunotherapy of Cancer, December 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

So far, Altmetric has seen 26 X posts from 21 X users, with an upper bound of 44,797 followers.

RT @sitcancer: #JITC Research: PI3Kα/δ inhibition promotes anti-tumor immunity through direct enhancement of effector CD8+ T-cell activity…

RT @sitcancer: #JITC Research: PI3Kα/δ inhibition promotes anti-tumor immunity through direct enhancement of effector CD8+ T-cell activity…

RT @sitcancer: #JITC Research: PI3Kα/δ inhibition promotes anti-tumor immunity through direct enhancement of effector CD8+ T-cell activity…

#JITC Research: PI3Kα/δ inhibition promotes anti-tumor immunity through direct enhancement of effector CD8+ T-cell activity https://t.co/7hI9imBVbZ https://t.co/XP4xyWRBB6

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 22 additional X posts.